KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNon-Current Deferred Tax LiabilityOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Amgen (AMGN) Intangibles (2016 - 2026)

Amgen has reported Intangibles over the past 18 years, most recently at $21.4 billion for Q1 2026.

  • For Q1 2026, Intangibles rose 345.4% year-over-year to $21.4 billion; the TTM value through Mar 2026 reached $21.4 billion, up 345.4%, while the annual FY2025 figure was $22.3 billion, 19.58% down from the prior year.
  • Intangibles for Q1 2026 was $21.4 billion at Amgen, down from $22.3 billion in the prior quarter.
  • Over five years, Intangibles peaked at $32.6 billion in Q4 2023 and troughed at $350.0 million in Q2 2025.
  • A 5-year average of $19.0 billion and a median of $16.1 billion in 2022 define the central range for Intangibles.
  • Biggest five-year swings in Intangibles: crashed 98.84% in 2025 and later soared 345.4% in 2026.
  • Year by year, Intangibles stood at $16.1 billion in 2022, then skyrocketed by 102.99% to $32.6 billion in 2023, then dropped by 15.14% to $27.7 billion in 2024, then fell by 19.58% to $22.3 billion in 2025, then fell by 4.03% to $21.4 billion in 2026.
  • Business Quant data shows Intangibles for AMGN at $21.4 billion in Q1 2026, $22.3 billion in Q4 2025, and $23.1 billion in Q3 2025.